Earnings Call: AtriCure Reports Strong Growth and Raises Full-Year Guidance
Daily NewsAtriCure, Inc. (NASDAQ: ATRC), a leading innovator in the management of atrial fibrillation and left atrial appendage treatments, reported revenues reaching $116 ...
Read More